Cleviprex and Oedema peripheral - a phase IV clinical study of FDA data


Oedema peripheral is reported only by a few people who take Cleviprex.

The phase IV clinical study analyzes which people take Cleviprex and have Oedema peripheral. It is created by eHealthMe based on reports of 173 people who have side effects while taking Cleviprex from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 16, 2022

173 people reported to have side effects when taking Cleviprex.
Among them, 3 people (1.73%) have Oedema peripheral.

What is Cleviprex?

Cleviprex has active ingredients of clevidipine butyrate. eHealthMe is studying from 174 Cleviprex users for its effectiveness, alternative drugs and more.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 3,336 drugs and 3,320 conditions by eHealthMe.

Number of Cleviprex and Oedema peripheral reports submitted per year:

Could Cleviprex cause Oedema peripheral?

Time on Cleviprex when people have Oedema peripheral *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Oedema peripheral when taking Cleviprex *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Oedema peripheral when taking Cleviprex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common side effects people have besides Oedema peripheral *:

  1. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 3 people, 100.00%
  2. Generalised Oedema (swelling all over the body): 3 people, 100.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 100.00%
  4. Breathing Difficulty: 3 people, 100.00%
  5. Colitis (inflammation of colon): 3 people, 100.00%
  6. Gastric Ulcer (stomach ulcer): 3 people, 100.00%
  7. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 100.00%
  8. Hypotension (abnormally low blood pressure): 3 people, 100.00%
  9. Agitation (state of anxiety or nervous excitement): 3 people, 100.00%
  10. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cleviprex and have Oedema peripheral?

Check whether Oedema peripheral is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oedema peripheral and when was it recovered:

Expand to all the drugs that have ingredients of clevidipine butyrate:

Alternative drugs to, pros and cons of Cleviprex:

Oedema peripheral treatments and more:

COVID vaccines that are related to Oedema peripheral:

Common drugs associated with Oedema peripheral:

All the drugs that are associated with Oedema peripheral:

Common conditions associated with Oedema peripheral:

All the conditions that are associated with Oedema peripheral:

How the study uses the data?

The study uses data from the FDA. It is based on clevidipine butyrate (the active ingredients of Cleviprex) and Cleviprex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: